EMQN join DEVOTE programme
EMQN CIC are delighted to be part of the DEVOTE programme, working with the partners (genedrive, Chromition, APIS Assay Technologies Ltd., Manchester University NHS Foundation Trust, Health Innovation Manchester) to deliver EQA for point-of-care testing in pharmacogenetics. Ensuring the delivery of high quality testing to support personalised treatment at the right time to improve patient […]
EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: State of the art 2023
[Correction added on 25 October 2023, after first online publication: Figure A1 has been replaced in this version.] Abstract Testing for AZoospermia Factor (AZF) deletions of the Y chromosome is a key component of the diagnostic workup of azoospermic and severely oligozoospermic men. This revision of the 2013 European Academy of Andrology (EAA) and EMQN […]
EMQN Best Practice Guidelines for Genetic Testing in Inherited Cardiomyopathies and Arrhythmias
Abstract Inherited cardiomyopathies and arrhythmias (ICAs) are a prevalent and clinically heterogeneous group of genetic disorders that are associated with increased risk of sudden cardiac death and heart failure. Making a genetic diagnosis can inform the management of patients and their at-risk relatives and, as such, molecular genetic testing is now considered an integral component […]
EMQN Position Statement: Use of LRG Reference Sequences for Variant Reporting
In recognition of the discontinuation of the LRG reference sequence project, EMQN CIC has published a position statement. For more information please see our webinar here. Supporting information on the MANE initiative can be found at the NCBI website or EBI website. Full statement
EMQN CIC to formally CPD accredit participation of EQA Assessors in 2023
EMQN CIC becomes an accredited provider of Continuing Professional Development (CPD) via CPD UK, and moves to formally accredit the participation of its volunteers / experts in the 2023 EQA assessment process PRESS RELEASE: Manchester, United Kingdom, 16th September 2022 – EMQN CIC announced today that from 2023, EQA assessment meetings will be formally CPD accredited. […]
